Tempus AI, Inc. short interest in 2025
In 2025, Tempus AI, Inc.'s disclosed short interest ran from 7.28% of shares outstanding on 15 Jan 2025 to 11.28% on 31 Dec 2025, a change of +4.00 percentage points. The year's high was 15.19% on 15 Sep 2025 and its low 7.28% on 15 Jan 2025, averaging 11.66% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.87 days on 15 Dec 2025. Full history: Tempus AI, Inc..
Cite this page
2025 in figures
- Start of year
- 7.28% (15 Jan 2025)
- End of year
- 11.28% (31 Dec 2025)
- Change
- +4.00 pp
- High
- 15.19% (15 Sep 2025)
- Low
- 7.28% (15 Jan 2025)
- Average
- 11.66%
- Highest days to cover
- 5.87 (15 Dec 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 7.28% | 2.75 | results (8-K) |
| 31 Jan 2025 | 7.99% | 1.00 | |
| 14 Feb 2025 | 8.09% | 1.00 | |
| 28 Feb 2025 | 8.23% | 1.00 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 9.99% | 1.61 | |
| 31 Mar 2025 | 11.59% | 1.92 | |
| 15 Apr 2025 | 12.03% | 2.03 | |
| 30 Apr 2025 | 11.02% | 2.01 | |
| 15 May 2025 | 12.17% | 1.34 | 10-Q filed, results (8-K) |
| 30 May 2025 | 12.44% | 1.21 | |
| 13 Jun 2025 | 11.33% | 1.34 | |
| 30 Jun 2025 | 12.73% | 2.26 | |
| 15 Jul 2025 | 13.85% | 2.87 | |
| 31 Jul 2025 | 13.38% | 2.57 | |
| 15 Aug 2025 | 14.95% | 2.14 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 14.00% | 2.17 | |
| 15 Sep 2025 | 15.19% | 2.98 | |
| 30 Sep 2025 | 13.72% | 2.65 | |
| 15 Oct 2025 | 12.74% | 2.72 | |
| 31 Oct 2025 | 11.98% | 3.58 | |
| 14 Nov 2025 | 12.47% | 3.03 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 11.28% | 4.12 | |
| 15 Dec 2025 | 10.18% | 5.87 | |
| 31 Dec 2025 | 11.28% | 5.11 |
See also: Tempus AI, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.